Skip to content

Dilon Technologies Inc. vs Lumicell

Dilon Technologies Inc. logo

Dilon Technologies Inc.

Dilon Technologies is a medical device company that focuses on products that assist in the fight against breast cancer

74 employees · est. 1999 · Newport News, United States

VS
Lumicell logo

Lumicell

Illuminate Cancer in Real Time

63 employees · est. 2009 · Waltham, United States

Dilon Technologies Inc. is the older company (1999 vs 2009).

Side-by-Side Comparison

Dilon Technologies Inc. Lumicell
Founded
1999 older 2009
Headquarters
Newport News, United States Waltham, United States
Employees
74 63
Industry
Biotechnology, Health Care Biotechnology, Hardware, Health Care
Funding Stage
Debt Financing Venture round
Total Funding
$9.49M $80.49M
Funding Rounds
4 8
Services
Not tracked yet Real-time cancer detection, Lumpectomy assistance, Fluorescence imaging technology
Target Customers
Not tracked yet Healthcare providers, Surgeons, Cancer treatment facilities, Biotech and Medtech professionals
Taxonomy
Breast ImagingMolecular Breast ImagingGeneral Nuclear MedicineGamma ProbesSpecimen Radiography SystemBreast Cancer +8 Cancer SurgeryFluorescence-Guided TechnologyImage-Guided SurgeryReal-Time IlluminationBreast Cancer SurgeryOptical Imaging Agent +8
Website
dilon.com lumicell.com
Dilon Technologies Inc. logo

About Dilon Technologies Inc.

Dilon Technologies Inc. is a medical device company headquartered in the United States, specializing in products that aid in the battle against breast cancer. The company, established in 1999, boasts a robust medical device portfolio, which includes the Navigator System, a renowned surgical gamma pr...

Lumicell logo

About Lumicell

Lumicell, with the slogan "Illuminate Cancer in Real Time," is a transformative player in the Biotechnology, Hardware, and Health Care sectors. Founded in 2009 and based in the United States, this privately held company is pioneering fluorescence-guided technologies aimed at enhancing cancer surgery...

Also comparing in this category

Comparing more than these two?

Get Dilon Technologies Inc., Lumicell and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Dilon Technologies Inc. compare?

A PDF of Dilon Technologies Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Dilon Technologies Inc. was founded in 1999, based in Newport News, United States, with 74 employees. Dilon Technologies Inc. is a medical device company headquartered in the United States, specializing in products that aid in the battle against breast cancer. The company, established in 1999, boasts. Lumicell was founded in 2009, based in Waltham, United States, with 63 employees. Lumicell, with the slogan "Illuminate Cancer in Real Time," is a transformative player in the Biotechnology, Hardware, and Health Care sectors. Founded in 2009 and based in the United States, this pri.
Dilon Technologies Inc. has raised $9.49M and Lumicell $80.49M. Latest stage: Dilon Technologies Inc. Debt Financing, Lumicell Venture round.
Both work in Biotechnology and Health Care and list breast cancer surgery and cancer surgery among their focus areas.

Compare Dilon Technologies Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Dilon Technologies Inc. on 14 Sep 2024, and Lumicell on 10 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout